Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POST MARKETING SURVEILLANCE TO OBSERVE THE SAFETY AND EFFICACY OF DUAVIVE TAB 0.45MG/20MG

NCT02792504 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02792504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02792504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POST MARKETING SURVEILLANCE TO OBSERVE THE SAFETY AND EFFICACY OF DUAVIVE TAB 0.45MG/20MG
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 29, 2016
Completion date
July 22, 2020
Enrollment
669 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

severe vasomotor symptom associated with menopause